Trends in academic productivity in the COVID-19 era: analysis of neurosurgical, stroke neurology, and neurointerventional literature.


Journal

Journal of neurointerventional surgery
ISSN: 1759-8486
Titre abrégé: J Neurointerv Surg
Pays: England
ID NLM: 101517079

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 04 08 2020
revised: 05 09 2020
accepted: 15 09 2020
pubmed: 2 10 2020
medline: 23 10 2020
entrez: 1 10 2020
Statut: ppublish

Résumé

Academic physicians aim to provide clinical and surgical care to their patients while actively contributing to a growing body of scientific literature. The coronavirus disease 2019 (COVID-19) pandemic has resulted in procedural-based specialties across the United States witnessing a sharp decline in their clinical volume and surgical cases. To assess the impact of COVID-19 on neurosurgical, stroke neurology, and neurointerventional academic productivity. The study compared the neurosurgical, stroke neurology, and neurointerventional academic output during the pandemic lockdown with the same time period in previous years. Editors from a sample of neurosurgical, stroke neurology, and neurointerventional journals provided the total number of original manuscript submissions, broken down by months, from the year 2016 to 2020. Manuscript submission was used as a surrogate metric for academic productivity. 8 journals were represented. The aggregated data from all eight journals as a whole showed that a combined average increase of 42.3% was observed on original submissions for 2020. As the average yearly percent increase using the 2016-2019 data for each journal exhibited a combined average increase of 11.2%, the rise in the yearly increase for 2020 in comparison was nearly fourfold. For the same journals in the same time period, the average percent of COVID-19 related publications from January to June of 2020 was 6.87%. There was a momentous increase in the number of original submissions for the year 2020, and its effects were uniformly experienced across all of our represented journals.

Sections du résumé

BACKGROUND BACKGROUND
Academic physicians aim to provide clinical and surgical care to their patients while actively contributing to a growing body of scientific literature. The coronavirus disease 2019 (COVID-19) pandemic has resulted in procedural-based specialties across the United States witnessing a sharp decline in their clinical volume and surgical cases.
OBJECTIVE OBJECTIVE
To assess the impact of COVID-19 on neurosurgical, stroke neurology, and neurointerventional academic productivity.
METHODS METHODS
The study compared the neurosurgical, stroke neurology, and neurointerventional academic output during the pandemic lockdown with the same time period in previous years. Editors from a sample of neurosurgical, stroke neurology, and neurointerventional journals provided the total number of original manuscript submissions, broken down by months, from the year 2016 to 2020. Manuscript submission was used as a surrogate metric for academic productivity.
RESULTS RESULTS
8 journals were represented. The aggregated data from all eight journals as a whole showed that a combined average increase of 42.3% was observed on original submissions for 2020. As the average yearly percent increase using the 2016-2019 data for each journal exhibited a combined average increase of 11.2%, the rise in the yearly increase for 2020 in comparison was nearly fourfold. For the same journals in the same time period, the average percent of COVID-19 related publications from January to June of 2020 was 6.87%.
CONCLUSION CONCLUSIONS
There was a momentous increase in the number of original submissions for the year 2020, and its effects were uniformly experienced across all of our represented journals.

Identifiants

pubmed: 32998982
pii: neurintsurg-2020-016710
doi: 10.1136/neurintsurg-2020-016710
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1049-1052

Informations de copyright

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Jae Eun Lee (JE)

Department of Neurosurgery, Baylor College of Medicine, Houston, Texas, USA.

Alina Mohanty (A)

Department of Neurosurgery, Baylor College of Medicine, Houston, Texas, USA.

Felipe C Albuquerque (FC)

Department of Neurosurgery, Barrow Neurological Institute, Phoenix, Arizona, USA.

William T Couldwell (WT)

Department of Neurosurgery, University of Utah, Salt Lake City, Utah, USA.

Elad I Levy (EI)

Neurosurgery, Jacobs School of Medicine University at Buffalo, Buffalo, New York, USA.
Neurosurgery, Gates Vascular Institute at Kaleida Health, Buffalo, New York, USA.

Edward C Benzel (EC)

Department of Neurosurgery, Cleveland Clinic, Cleveland, Ohio, USA.

Ajay K Wakhloo (AK)

Neurointerventional Radiology, Lahey Hospital and Medical Center, Burlington, Massachusetts, USA.

Joshua A Hirsch (JA)

NeuroEndovascular Program, Massachusetts General Hospital, Boston, Massachusetts, USA.

David Fiorella (D)

Department of Neurosurgery, Stony Brook University, Stony Brook, New York, USA.
Department of Radiology, Stony Brook University, Stony Brook, New York, USA.

Kyle M Fargen (KM)

Neurological Surgery and Radiology, Wake Forest University, Winston-Salem, North Carolina, USA.

Jan-Karl Burkhardt (JK)

Department of Neurosurgery, Baylor College of Medicine, Houston, Texas, USA.
Department of Neurosurgery, Texas Children's Hospital, Houston, Texas, USA.

Visish M Srinivasan (VM)

Department of Neurosurgery, Baylor College of Medicine, Houston, Texas, USA.

Jeremiah Johnson (J)

Department of Neurosurgery, Baylor College of Medicine, Houston, Texas, USA.

Maxim Mokin (M)

Department of Neurosurgery, University of South Florida, Tampa, Florida, USA.

Peter Kan (P)

Department of Neurosurgery, University of Texas Medical Branch, Galveston, Texas, USA ptkan@utmb.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH